Canada must hit the U.S. where it hurts most: its lucrative patents

Under the World Trade Organization and section 19 of Canada’s Patent Act, Canada can circumvent U.S.-controlled patents, freeing up Canadian companies to make patented drugs as well as develop AI-based inventions and other key technologies to sell predominantly in Canada but also around the world. Given the national emergency that Trump’s Tariffs would create, Canada could immediately seek permission to accord these rights from the Commissioner of Patents, a public servant in charge of the Canadian patent office.